Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash-to-Debt No Debt
SPAN's Cash-to-Debt is ranked higher than
97% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.54 vs. SPAN: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
SPAN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04  Med: No Debt Max: No Debt
Current: No Debt
Equity-to-Asset 0.85
SPAN's Equity-to-Asset is ranked higher than
88% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. SPAN: 0.85 )
Ranked among companies with meaningful Equity-to-Asset only.
SPAN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.48  Med: 0.77 Max: 0.87
Current: 0.85
0.48
0.87
Interest Coverage No Debt
SPAN's Interest Coverage is ranked higher than
96% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 73.23 vs. SPAN: No Debt )
Ranked among companies with meaningful Interest Coverage only.
SPAN' s Interest Coverage Range Over the Past 10 Years
Min: 69.61  Med: 681.22 Max: No Debt
Current: No Debt
Piotroski F-Score: 6
Altman Z-Score: 13.94
Beneish M-Score: -2.57
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 9.97
SPAN's Operating Margin % is ranked higher than
68% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.45 vs. SPAN: 9.97 )
Ranked among companies with meaningful Operating Margin % only.
SPAN' s Operating Margin % Range Over the Past 10 Years
Min: 6.46  Med: 10.15 Max: 13.42
Current: 9.97
6.46
13.42
Net Margin % 8.13
SPAN's Net Margin % is ranked higher than
71% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.77 vs. SPAN: 8.13 )
Ranked among companies with meaningful Net Margin % only.
SPAN' s Net Margin % Range Over the Past 10 Years
Min: 4.64  Med: 6.86 Max: 8.61
Current: 8.13
4.64
8.61
ROE % 18.69
SPAN's ROE % is ranked higher than
87% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 2.13 vs. SPAN: 18.69 )
Ranked among companies with meaningful ROE % only.
SPAN' s ROE % Range Over the Past 10 Years
Min: 8.52  Med: 16.7 Max: 31.29
Current: 18.69
8.52
31.29
ROA % 15.41
SPAN's ROA % is ranked higher than
94% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 0.49 vs. SPAN: 15.41 )
Ranked among companies with meaningful ROA % only.
SPAN' s ROA % Range Over the Past 10 Years
Min: 7.17  Med: 13.31 Max: 20.31
Current: 15.41
7.17
20.31
ROC (Joel Greenblatt) % 45.60
SPAN's ROC (Joel Greenblatt) % is ranked higher than
83% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 6.15 vs. SPAN: 45.60 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SPAN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 24.67  Med: 46.41 Max: 58.91
Current: 45.6
24.67
58.91
3-Year Revenue Growth Rate -0.20
SPAN's 3-Year Revenue Growth Rate is ranked lower than
68% of the 239 Companies
in the Global Medical Devices industry.

( Industry Median: 5.30 vs. SPAN: -0.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SPAN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -6.1  Med: 5.3 Max: 16.8
Current: -0.2
-6.1
16.8
3-Year EBITDA Growth Rate -2.80
SPAN's 3-Year EBITDA Growth Rate is ranked lower than
68% of the 210 Companies
in the Global Medical Devices industry.

( Industry Median: 6.30 vs. SPAN: -2.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SPAN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -18.5  Med: 2.2 Max: 46.6
Current: -2.8
-18.5
46.6
3-Year EPS without NRI Growth Rate -3.10
SPAN's 3-Year EPS without NRI Growth Rate is ranked lower than
59% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. SPAN: -3.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SPAN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -33.8  Med: 2.1 Max: 133.9
Current: -3.1
-33.8
133.9
GuruFocus has detected 5 Warning Signs with Span-America Medical Systems Inc $SPAN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SPAN's 30-Y Financials

Financials (Next Earnings Date: 2017-08-05 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

SPAN Guru Trades in Q2 2016

Jim Simons 70,200 sh (+2.78%)
» More
Q3 2016

SPAN Guru Trades in Q3 2016

Jim Simons 72,401 sh (+3.14%)
» More
Q4 2016

SPAN Guru Trades in Q4 2016

Jim Simons 77,600 sh (+7.18%)
» More
Q1 2017

SPAN Guru Trades in Q1 2017

Jim Simons 85,100 sh (+9.66%)
» More
» Details

Insider Trades

Latest Guru Trades with SPAN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:NAS:DRAD, NAS:IRMD, NAS:EYES, NAS:MSON, NAS:CGNT, NAS:PAVM, ASX:VTI, OTCPK:BTCY, NAS:IRIX, NAS:ACRX, TSXV:HTL, TSXV:PHM, NAS:SRTS, AMEX:ELMD, ASX:AXP, OTCPK:IVOB, OTCPK:BSGM, NAS:MGCD, LSE:EGI, NAS:ETRM » details
Headquarter Location:USA
Span-America Medical Systems Inc manufactures and distributes therapeutic support surfaces and related products using polyurethane foam and other foam products and materials for the medical, consumer and industrial markets.

Span-America Medical Systems Inc was incorporated under the laws of the state of South Carolina on September 21, 1970. The Company manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Its operations are divided into two main business units or segments: medical and custom products. The Company's main medical products consist of polyurethane foam mattress overlays, therapeutic support surfaces (which consist of non-powered and powered therapeutic support surfaces) and patient positioners as well as Selan (r) skin care, seating and fall protection products. The Company's custom products segment includes two product lines namely consumer bedding products and various engineered industrial products. The Company's consumer product line consists mainly of convoluted and contour-cut mattress overlays and specially designed pillows for the consumer bedding market. It sells these products mainly in North America to customers in the segments of the health care market, including acute care hospitals, long-term care facilities and home health care providers. The Company's manufacturing operations are subject to various government regulations pertaining to the discharge of materials into the environment.

Ratios

vs
industry
vs
history
PE Ratio 16.48
SPAN's PE Ratio is ranked higher than
79% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 30.71 vs. SPAN: 16.48 )
Ranked among companies with meaningful PE Ratio only.
SPAN' s PE Ratio Range Over the Past 10 Years
Min: 4.97  Med: 11.47 Max: 22.57
Current: 16.48
4.97
22.57
PE Ratio without NRI 16.48
SPAN's PE Ratio without NRI is ranked higher than
79% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 31.10 vs. SPAN: 16.48 )
Ranked among companies with meaningful PE Ratio without NRI only.
SPAN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.94  Med: 10.72 Max: 22.57
Current: 16.48
4.94
22.57
Price-to-Owner-Earnings 16.51
SPAN's Price-to-Owner-Earnings is ranked higher than
79% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 36.31 vs. SPAN: 16.51 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
SPAN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.49  Med: 11.77 Max: 32.16
Current: 16.51
5.49
32.16
PB Ratio 2.89
SPAN's PB Ratio is ranked higher than
52% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. SPAN: 2.89 )
Ranked among companies with meaningful PB Ratio only.
SPAN' s PB Ratio Range Over the Past 10 Years
Min: 1.21  Med: 1.91 Max: 5.6
Current: 2.89
1.21
5.6
PS Ratio 1.34
SPAN's PS Ratio is ranked higher than
75% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 3.32 vs. SPAN: 1.34 )
Ranked among companies with meaningful PS Ratio only.
SPAN' s PS Ratio Range Over the Past 10 Years
Min: 0.4  Med: 0.79 Max: 1.42
Current: 1.34
0.4
1.42
Price-to-Free-Cash-Flow 21.28
SPAN's Price-to-Free-Cash-Flow is ranked higher than
71% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 32.13 vs. SPAN: 21.28 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
SPAN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.24  Med: 11.09 Max: 31.17
Current: 21.28
5.24
31.17
Price-to-Operating-Cash-Flow 18.96
SPAN's Price-to-Operating-Cash-Flow is ranked higher than
53% of the 135 Companies
in the Global Medical Devices industry.

( Industry Median: 19.50 vs. SPAN: 18.96 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
SPAN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 4.57  Med: 9.74 Max: 22.56
Current: 18.96
4.57
22.56
EV-to-EBIT 11.01
SPAN's EV-to-EBIT is ranked higher than
82% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 24.67 vs. SPAN: 11.01 )
Ranked among companies with meaningful EV-to-EBIT only.
SPAN' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.1  Med: 7 Max: 14.8
Current: 11.01
3.1
14.8
EV-to-EBITDA 9.47
SPAN's EV-to-EBITDA is ranked higher than
78% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 17.99 vs. SPAN: 9.47 )
Ranked among companies with meaningful EV-to-EBITDA only.
SPAN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.8  Med: 6.1 Max: 11.1
Current: 9.47
2.8
11.1
Shiller PE Ratio 18.94
SPAN's Shiller PE Ratio is ranked higher than
92% of the 53 Companies
in the Global Medical Devices industry.

( Industry Median: 49.44 vs. SPAN: 18.94 )
Ranked among companies with meaningful Shiller PE Ratio only.
SPAN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.03  Med: 13.16 Max: 38.18
Current: 18.94
9.03
38.18
Current Ratio 4.78
SPAN's Current Ratio is ranked higher than
78% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.64 vs. SPAN: 4.78 )
Ranked among companies with meaningful Current Ratio only.
SPAN' s Current Ratio Range Over the Past 10 Years
Min: 2.21  Med: 3.59 Max: 5.24
Current: 4.78
2.21
5.24
Quick Ratio 3.28
SPAN's Quick Ratio is ranked higher than
69% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. SPAN: 3.28 )
Ranked among companies with meaningful Quick Ratio only.
SPAN' s Quick Ratio Range Over the Past 10 Years
Min: 1.37  Med: 2.58 Max: 3.92
Current: 3.28
1.37
3.92
Days Inventory 71.32
SPAN's Days Inventory is ranked higher than
80% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 128.08 vs. SPAN: 71.32 )
Ranked among companies with meaningful Days Inventory only.
SPAN' s Days Inventory Range Over the Past 10 Years
Min: 37.51  Med: 58.43 Max: 71.32
Current: 71.32
37.51
71.32
Days Sales Outstanding 43.93
SPAN's Days Sales Outstanding is ranked higher than
83% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.17 vs. SPAN: 43.93 )
Ranked among companies with meaningful Days Sales Outstanding only.
SPAN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.24  Med: 43.1 Max: 49.7
Current: 43.93
38.24
49.7
Days Payable 23.54
SPAN's Days Payable is ranked lower than
84% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 54.45 vs. SPAN: 23.54 )
Ranked among companies with meaningful Days Payable only.
SPAN' s Days Payable Range Over the Past 10 Years
Min: 17.2  Med: 23.53 Max: 34.51
Current: 23.54
17.2
34.51

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.13
SPAN's Dividend Yield % is ranked higher than
75% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 1.14 vs. SPAN: 2.13 )
Ranked among companies with meaningful Dividend Yield % only.
SPAN' s Dividend Yield % Range Over the Past 10 Years
Min: 0.89  Med: 2.72 Max: 4.38
Current: 2.13
0.89
4.38
Dividend Payout Ratio 0.35
SPAN's Dividend Payout Ratio is ranked higher than
53% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 0.37 vs. SPAN: 0.35 )
Ranked among companies with meaningful Dividend Payout Ratio only.
SPAN' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.16  Med: 0.29 Max: 0.66
Current: 0.35
0.16
0.66
3-Year Dividend Growth Rate 7.50
SPAN's 3-Year Dividend Growth Rate is ranked lower than
61% of the 76 Companies
in the Global Medical Devices industry.

( Industry Median: 11.10 vs. SPAN: 7.50 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
SPAN' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 7.5 Max: 27.4
Current: 7.5
0
27.4
Forward Dividend Yield % 2.13
SPAN's Forward Dividend Yield % is ranked higher than
72% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 1.51 vs. SPAN: 2.13 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.26
SPAN's 5-Year Yield-on-Cost % is ranked higher than
74% of the 235 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. SPAN: 3.26 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SPAN' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.36  Med: 4.17 Max: 6.71
Current: 3.26
1.36
6.71
3-Year Average Share Buyback Ratio 2.00
SPAN's 3-Year Average Share Buyback Ratio is ranked higher than
95% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: -4.10 vs. SPAN: 2.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SPAN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -2.4  Med: -0.5 Max: 8.3
Current: 2
-2.4
8.3

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 40.53
SPAN's Price-to-Net-Cash is ranked lower than
76% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 15.73 vs. SPAN: 40.53 )
Ranked among companies with meaningful Price-to-Net-Cash only.
SPAN' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 5.19  Med: 25.47 Max: 441
Current: 40.53
5.19
441
Price-to-Net-Current-Asset-Value 4.52
SPAN's Price-to-Net-Current-Asset-Value is ranked higher than
67% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: 6.83 vs. SPAN: 4.52 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
SPAN' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.22  Med: 3.51 Max: 46.09
Current: 4.52
1.22
46.09
Price-to-Tangible-Book 3.61
SPAN's Price-to-Tangible-Book is ranked higher than
53% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 3.98 vs. SPAN: 3.61 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
SPAN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.68  Med: 1.64 Max: 5.88
Current: 3.61
0.68
5.88
Price-to-Intrinsic-Value-Projected-FCF 1.27
SPAN's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
84% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 2.41 vs. SPAN: 1.27 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
SPAN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.32  Med: 0.78 Max: 2.59
Current: 1.27
0.32
2.59
Price-to-Median-PS-Value 1.70
SPAN's Price-to-Median-PS-Value is ranked lower than
81% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. SPAN: 1.70 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SPAN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.44  Med: 0.81 Max: 1.7
Current: 1.7
0.44
1.7
Price-to-Graham-Number 1.63
SPAN's Price-to-Graham-Number is ranked higher than
62% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. SPAN: 1.63 )
Ranked among companies with meaningful Price-to-Graham-Number only.
SPAN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.58  Med: 0.97 Max: 2.09
Current: 1.63
0.58
2.09
Earnings Yield (Greenblatt) % 9.08
SPAN's Earnings Yield (Greenblatt) % is ranked higher than
90% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. SPAN: 9.08 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SPAN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 6.8  Med: 14.2 Max: 32.2
Current: 9.08
6.8
32.2
Forward Rate of Return (Yacktman) % 1.61
SPAN's Forward Rate of Return (Yacktman) % is ranked lower than
69% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.78 vs. SPAN: 1.61 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
SPAN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 0.8  Med: 9.45 Max: 44.9
Current: 1.61
0.8
44.9

More Statistics

Revenue (TTM) (Mil) $61.77
EPS (TTM) $ 1.82
Short Percentage of Float0.36%
52-Week Range $17.05 - 31.00
Shares Outstanding (Mil)2.76
» More Articles for SPAN

Headlines

Articles On GuruFocus.com
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Span-America Me May 26 2017 
Lifshitz & Miller LLP Announces Investigation of Angie's List, Inc., Care Capital Properties, Inc., May 15 2017 
Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Span-America M May 10 2017 
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Span May 09 2017 
WeissLaw LLP: The Span-America Medical Systems, Inc. Acquisition May Not Be In The Best Interests of May 05 2017 
7 Stocks Paying More Cash with Higher Dividends Aug 12 2013 
Span-America Medical Systems: 92nd Consecutive Dividend and Debt Free Dec 04 2012 
Heinz Increases Dividend 7.3%, And These 5 Other Stocks Raised Dividends May 28 2012 
Guru Stocks Raising Dividends: CATO, POR, VIA, SPAN, HPQ May 28 2012 
11 Cheapest Healthcare Dividend Stocks to Consider Aug 02 2011 

More From Other Websites
Span-America Medical Systems, Inc. :SPAN-US: Earnings Analysis: Q2, 2017 By the Numbers : June 19,... Jun 19 2017
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Span-America... May 26 2017
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Span-America... May 16 2017
Lifshitz & Miller LLP Announces Investigation of Angie's List, Inc., Care Capital Properties, Inc.,... May 15 2017
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Span-America... May 10 2017
Act Now - Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of Span-America... May 10 2017
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of... May 09 2017
Span-America Medical Systems, Inc. : SPAN-US: Dividend Analysis : May 11th, 2017 (record date) : By... May 09 2017
SPAN-AMERICA MEDICAL SYSTEMS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation... May 09 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Whether the Sale of... May 05 2017
WeissLaw LLP: The Span-America Medical Systems, Inc. Acquisition May Not Be In The Best Interests of... May 05 2017
Span-America Reports Second Quarter Fiscal 2017 Results May 04 2017
Span-America Medical Systems, Inc.: Strong price momentum but will it sustain? May 03 2017
ETFs with exposure to Span-America Medical Systems, Inc. : May 2, 2017 May 02 2017
Span-America Medical Systems, Inc. Announces Preliminary Results for Second Quarter May 01 2017
Span-America Medical Systems, Inc. Agrees to Be Acquired by Savaria Corporation May 01 2017
ETFs with exposure to Span-America Medical Systems, Inc. : April 10, 2017 Apr 10 2017
Span-America Medical Systems, Inc. :SPAN-US: Earnings Analysis: Q1, 2017 By the Numbers : March 8,... Mar 08 2017
Span-America Medical Systems, Inc. : SPAN-US: Dividend Analysis : March 07th, 2017 (record date) :... Mar 03 2017
Span-America Shareholders Elect Directors, Approve Stock Plan and Select Auditors at Annual Meeting Feb 27 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}